Dolby Laboratories’ (DLB) “Buy” Rating Reiterated at Rosenblatt Securities

Dolby Laboratories (NYSE:DLBGet Free Report)‘s stock had its “buy” rating restated by equities research analysts at Rosenblatt Securities in a research note issued to investors on Friday,Benzinga reports. They currently have a $85.00 price target on the electronics maker’s stock. Rosenblatt Securities’ price target points to a potential upside of 36.07% from the company’s previous close.

A number of other equities analysts have also weighed in on the stock. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings downgraded shares of Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Finally, Barrington Research restated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, June 15th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $83.00.

Get Our Latest Report on Dolby Laboratories

Dolby Laboratories Price Performance

DLB stock opened at $62.47 on Friday. The stock has a market capitalization of $5.85 billion, a P/E ratio of 26.58 and a beta of 0.80. The business has a fifty day moving average price of $55.49 and a 200-day moving average price of $58.50. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $73.78.

Dolby Laboratories (NYSE:DLBGet Free Report) last issued its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The firm had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. During the same quarter in the previous year, the firm posted $0.78 EPS. The company’s revenue for the quarter was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, analysts anticipate that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories announced that its Board of Directors has authorized a stock buyback plan on Thursday, July 30th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to buy up to 7% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

Insider Transactions at Dolby Laboratories

In other news, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $60.00, for a total value of $460,020.00. Following the completion of the sale, the senior vice president owned 118,727 shares in the company, valued at approximately $7,123,620. This trade represents a 6.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $62.71, for a total transaction of $188,130.00. Following the transaction, the senior vice president directly owned 73,274 shares of the company’s stock, valued at approximately $4,595,012.54. This represents a 3.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 28,888 shares of company stock worth $1,664,918. 37.93% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Dolby Laboratories

Several hedge funds have recently made changes to their positions in the company. Paragon Capital Management Inc. bought a new position in Dolby Laboratories during the 1st quarter worth about $1,306,000. Hsbc Holdings PLC increased its position in Dolby Laboratories by 396.1% during the 1st quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock valued at $1,875,000 after purchasing an additional 24,958 shares during the period. Norges Bank bought a new stake in shares of Dolby Laboratories in the 4th quarter valued at about $54,966,000. Entropy Technologies LP bought a new stake in shares of Dolby Laboratories in the 1st quarter valued at about $1,674,000. Finally, Pacer Advisors Inc. lifted its position in shares of Dolby Laboratories by 8.0% in the 1st quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock worth $31,008,000 after purchasing an additional 38,389 shares during the period. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Dolby Laboratories News Summary

Here are the key news stories impacting Dolby Laboratories this week:

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Articles

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.